文献速递癫痫

迷走神经刺激、脑深部电刺激及其联合治疗Lennox-Gastaut综合征的癫痫发作结局比较

Comparative Seizure Outcomes of Vagus Nerve Stimulation, Deep Brain Stimulation, and Their Combination in Lennox-Gastaut Syndrome.
PubMed 文献 · Ann Neurol · 2026-07-14

24个月时VNS与DBS总体队列的发作减少率无显著差异,但三组间存在显著差异,DBS+VNS的减少率显著优于DBS单用或VNS单用。

要点

  • 24个月时VNS与DBS总体队列的发作减少率无显著差异(p=0.54)。
  • DBS+VNS组发作减少率显著高于DBS单用组(padj=0.027)和VNS单用组(padj=0.048)。
  • 本小样本回顾性数据提示DBS+VNS可能带来进一步发作减少,需进一步研究。

核心结论

  • 在LGS患者2年随访中,VNS与DBS提供相当的癫痫发作减少效果。
  • DBS+VNS联合治疗在本小型回顾性数据集中与更优的发作减少相关,值得进一步研究。

研究设计与样本

  • 在刺激后6、12、24个月评估癫痫发作频率,应答定义为发作减少≥50%。

主要发现

  • 24个月时VNS组中位发作减少率为50%(95%CI 44–75%),DBS总体队列为59%(95%CI 33–86%),两者比较p=0.54。
  • 三治疗组间比较差异显著(p=0.027)。
  • DBS+VNS组中位减少率为81%(95%CI 60–99%),显著高于DBS单用组的43%(95%CI 0–58%,padj=0.027)。
  • DBS+VNS组中位减少率也显著高于VNS单用组的50%(95%CI 44.4–75.0%,padj=0.048)。
  • 4例患者在末次随访时达到持续无发作超过1年。

关键数值与推荐

  • 应答定义为癫痫发作减少≥50%。
  • 24个月时VNS组中位发作减少率50%(95%CI 44–75%),DBS总体队列59%(95%CI 33–86%)。
  • 24个月时DBS+VNS组中位发作减少率81%(95%CI 60–99%),DBS单用组43%(95%CI 0–58%),VNS单用组50%(95%CI 44.4–75.0%)。

临床怎么用

  • 对于LGS患者,VNS与DBS单用均可作为神经调控选择,2年发作减少效果相当。
  • 在部分筛选患者中,DBS+VNS联合治疗可能带来额外发作减少获益,但需结合小样本回顾性证据谨慎评估。

局限性

  • 本研究为小样本回顾性队列,联合治疗组仅10例,结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Lennox-Gastaut syndrome (LGS) is a severe treatment-resistant epilepsy. Although vagus nerve stimulation (VNS) and deep brain stimulation (DBS) are established therapies, comparative data and the impact of dual neuromodulation remain limited. We compared seizure outcomes across VNS, DBS, and combined DBS + VNS therapy in LGS. METHODS: This retrospective cohort study at Mayo Clinic (2005-2024) included LGS patients treated with VNS and/or DBS. Seizure frequency was assessed at 6, 12, and 24 months post-stimulation. Responder was defined as 50% or more seizure reduction. RESULTS: Forty patients were included (42% female, median, 150 seizures/month). Eleven patients underwent sequential VNS followed by DBS and contributed data to 2 treatment epochs, yielding 3 treatment groups: VNS alone (n = 29), DBS alone (n = 12), and DBS + VNS (n = 10). At 24 months, median seizure reduction rate was comparable between VNS (50%; 95% confidence interval [CI], 44-75%) and the overall DBS cohort (59%, 95% CI, 33-86%) (p = 0.54). However, a significant difference emerged when comparing the 3 treatment arms (p = 0.027). Specifically, DBS + VNS therapy yielded significantly greater median reduction rate (81%, 95% CI, 60-99%) than DBS alone (43%, 95% CI, 0-58%) (padj = 0.027) or VNS alone (50%, 95% CI, 44.4-75.0%) (padj = 0.048). Four patients attained sustained seizure freedom above 1 year at last follow-up. INTERPRETATION: VNS and DBS provide comparable seizure reduction in LGS over a 2-year follow-up period. DBS + VNS was associated with further improvements in seizure reduction in this small, retrospective dataset. This possibility warrants further investigation. ANN NEUROL 2026;100:879-892.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Kuo CY, Singh R, Sharma S, et al. Comparative Seizure Outcomes of Vagus Nerve Stimulation, Deep Brain Stimulation, and Their Combination in Lennox-Gastaut Syndrome. Ann Neurol. 2026. PMID: 42446202. doi:10.1002/ana.78308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。